CareFusion (NYS: CFN) carries $3.8 billion of goodwill and other intangibles on its balance sheet. Sometimes goodwill, especially when it's excessive, can foreshadow problems down the road. Could this ...

A federal judge in California dealt a setback to CareFusion Corp. (NYSE:CFN) in its anti-trust and patent infringement lawsuit against Medtronic Inc. (NYSE:MDT), tossing the anti-trust claims but ...

(Reuters) - Medical equipment supplier Becton Dickinson & Co (BDX.N) has agreed to buy CareFusion Corp (CFN.N), a maker of infusion pumps and other medical devices, for $12.2 billion (7.64 billion ...

SAN DIEGO, Oct. 4, 2012 /PRNewswire/ -- CareFusion and Cerner today announced the implementation of interconnected systems that share data for enhanced medication management at Penn State Milton S.

The announcement triggered a 1.9% rise in CareFusion‘s share price in the trading session. The exclusive products of Terumo, namely SurFlash and SurFlash Plus Safety IV Catheters, are part of this new ...

Investors considering a purchase of CareFusion Corp (NYSE: CFN) stock, but cautious about paying the going market price of $58.92/share, might benefit from considering selling puts among the ...

Executives at CareFusion are combining medicine and music to publicize the company’s launch as a solo act. Company officials last month launched the CareFusion Jazz Festival Series, an international ...

CareFusion has announced it has reached an agreement with Epic to make bi-directional connectivity available between CareFusion’s Alaris system and Epic’s electronic medical record platform, according ...

Medical technology company CareFusion (CFN) recently announced an agreement for the acquisition of privately-owned Brazilian company, Intermed Equipamento Medico Hospitalar Ltda. Sao Paulo-based ...

Keep your eye on margins. Margins matter. The more CareFusion (NYSE: CFN) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) ...

A lot of attention has historically been paid to CareFusion Corporation in the context of its place in the infusion pump oligopoly with Baxter and Hospira. There is a lot more to this story, though, ...

Don't just count the cash, time it. It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When ...